Implementation of an Outpatient HD-MTX Initiative
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.773397
Abstract: Introduction Methotrexate (MTX) a folate antagonist is often given in high doses (≥500 mg/m2) to treat a variety of disease processes. While inpatient administration has been the norm, outpatient administration, has been shown to be… read more here.
Keywords: implementation outpatient; mtx initiative; outpatient; methotrexate ... See more keywords